Research Library

The safety and efficacy of many stem cell treatments remain unproven by the FDA, yet state laws promote access and use of these unchecked and potentially harmful treatments. Fellow Kirstin R.W. Matthews summarizes her recent publication in a new commentary — outlining public health consequences of these state laws and calling for scientific societies’ advocacy in state policymaking.

In this episode of Baker Briefing, experts explore the future of fuels for passenger and freight mobility. The episode is part of an initiative by the Center for Energy Studies investigating the supply chain and cost implications of transitioning fuels across the transportation sector — the economy’s circulatory system.